Veterinary api Ingredients, animal nutrition raw materials and feed additives manufacturer and supplier

Company News

Novartis might face legal action, penalty for faking documents

Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India. The drug regulator, Drugs Controller General of India (DCGI), has already cancelled the company’s import licences as well as existing registration certificate for the product.“Our application for the renewal or re-registration of Tiamulin Hydrogen Fumarate (80 per cent granules) has been rejected by the DCGI.

上一个:no more!下一个:no more!

Latest News

Contact Us



Email:[email protected]

ADD: Room C405, No. 488,Cuishan Rd, Xishan District, Wuxi City Jiangsu Province, China